B
Bhuvaneshwar Vaidya
Researcher at Texas Tech University Health Sciences Center
Publications - 67
Citations - 3212
Bhuvaneshwar Vaidya is an academic researcher from Texas Tech University Health Sciences Center. The author has contributed to research in topics: Drug delivery & Liposome. The author has an hindex of 28, co-authored 65 publications receiving 2435 citations. Previous affiliations of Bhuvaneshwar Vaidya include Dr. Hari Singh Gour University & Keck Graduate Institute of Applied Life Sciences.
Papers
More filters
Journal ArticleDOI
Zinc oxide nanoparticles: a promising nanomaterial for biomedical applications.
TL;DR: Zinc oxide NPs have been successfully exploited as drug carriers for loading and transporting drugs to target sites, thereby reducing unwanted toxicity and off-target effects, and resulting in amplified synergistic effects.
Journal ArticleDOI
Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
Rishi Paliwal,Shivani Rai,Bhuvaneshwar Vaidya,Kapil Khatri,Amit K. Goyal,Neeraj Mishra,Abhinav Mehta,Suresh P. Vyas +7 more
TL;DR: The comparative study conducted on methotrexate (MTX)-bearing SLNs revealed that the formulation based on Compritol 888 ATO could noticeably improve the oral bioavailability of MTX, presumably following SLNs constituting lipid digestion and co-absorption through lymphatic transport and route.
Journal ArticleDOI
Metal nanoparticles: a theranostic nanotool against cancer.
TL;DR: Metal nanoparticles are proposed as one of the most promising theranostic agents for the treatment of cancer, and have potential as anticancer agents, either inherently or as a result of surface modifications.
Journal ArticleDOI
Microfluidics-based 3D cell culture models: Utility in novel drug discovery and delivery research.
Nilesh Gupta,Jeffrey Liu,Brijeshkumar Patel,Deepak E. Solomon,Bhuvaneshwar Vaidya,Vivek Gupta +5 more
TL;DR: This review highlights the most significant developments in the field of microfluidic 3D culture over the past half‐decade with a special focus on their benefits and challenges down the lane.
Journal ArticleDOI
Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke
TL;DR: This review will focus on the different stages and mechanisms of BBB damage in acute ischemic stroke and novel therapeutic strategies to target those pathways for better therapeutic outcome in stroke.